Search Results - "Gronberg, B.H."

  • Showing 1 - 19 results of 19
Refine Results
  1. 1

    Strategies for clinical implementation of TNM-Immunoscore in resected nonsmall-cell lung cancer by Donnem, T., Kilvaer, T.K., Andersen, S., Richardsen, E., Paulsen, E.E., Hald, S.M., Al-Saad, S., Brustugun, O.T., Helland, A., Lund-Iversen, M., Solberg, S., Gronberg, B.H., Wahl, S.G.F., Helgeland, L., Fløtten, O., Pohl, M., Al-Shibli, K., Sandanger, T.M., Pezzella, F., Busund, L.T., Bremnes, R.M.

    Published in Annals of oncology (01-02-2016)
    “…Immunoscore is a prognostic tool defined to quantify in situ immune cell infiltrates and appears highly promising as a supplement to the tumor–node–metastasis…”
    Get full text
    Journal Article
  2. 2

    Does chemotherapy improve health-related quality of life in advanced pancreatic cancer? A systematic review by Kristensen, A, Vagnildhaug, O.M, Grønberg, B.H, Kaasa, S, Laird, B, Solheim, T.S

    Published in Critical reviews in oncology/hematology (01-03-2016)
    “…Abstract Chemotherapy is increasingly being used in advanced pancreatic cancer, but side-effects are common. The aim of this systematic review was to assess…”
    Get full text
    Journal Article
  3. 3
  4. 4

    The length of consent documents in oncological trials is doubled in twenty years by Berger, O., Grønberg, B. H., Sand, K., Kaasa, S., Loge, J. H.

    Published in Annals of oncology (01-02-2009)
    “…Background: The aim of the study was to investigate whether the length of informed consent documents (ICDs) for oncological trials have increased from 1987 to…”
    Get full text
    Journal Article
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19